← back to search

Yasser Bustanji

University of Jordan · JO
Area of research
Molecular Biology · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Natural Antidiabetic Agents Studies, Pharmacology and Obesity Treatment, Metabolomics and Mass Spectrometry Studies, and Essential Oils and Antimicrobial Activity.
h-index
56
citations
27,303
works
257
NIH funding
primary concept
Medicine
email

Recent publications

Ononin synergistically enhances the cytotoxic effect of doxorubicin in MDA-MB-231 triple-negative breast cancer cell line
Pharmacia 2026cited by 1position: contributordoi
Exploring the Impact of Two DNA Minor Groove Binder Compounds on HCT-116 Cells: A Comprehensive Multiomics Analysis Using Mass Spectrometry.
2026cited by 0position: contributordoi
The global, regional, and national burden attributable to low bone mineral density, 1990–2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021
The Lancet Rheumatology 2025cited by 15position: middledoi
The burden of bacterial antimicrobial resistance in the WHO Eastern Mediterranean Region 1990–2021: a cross-country systematic analysis with forecasts to 2050
The Lancet Public Health 2025cited by 15position: middledoi
Global, regional, and national burden of Chagas disease, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
The Lancet Infectious Diseases 2025cited by 9position: middledoi
Exploring the Anticancer Effect of <i>Artemisia herba-alba</i> on Colorectal Cancer: Insights From Eight Colorectal Cancer Cell Lines.
2025cited by 4position: contributordoi
The Aryl Hydrocarbon Receptor (AhR) Is a Novel Gene Involved in Proper Physiological Functions of Pancreatic β-Cells.
2025cited by 4position: contributordoi
Phytochemical composition and antiviral properties of A. fragrantissima methanolic extract on H1N1 virus
Pharmacia 2025cited by 3position: contributordoi
Advancements and global perspectives in the green synthesis of silver nanoparticles: A two-decade analysis
Pharmacia 2025cited by 3position: contributordoi
RETRACTED: Tarawneh et al. Berberine Inhibited Growth and Migration of Human Colon Cancer Cell Lines by Increasing Phosphatase and Tensin and Inhibiting Aquaporins 1, 3 and 5 Expressions. &lt;i&gt;Molecules&lt;/i&gt; 2023, &lt;i&gt;28&lt;/i&gt;, 3823.
2025cited by 0position: contributordoi
Untargeted Multiomics of LNCaP Cell Line Treated with a Novel DNA Minor Groove Binder and/or Doxorubicin Using Mass Spectrometry.
2025cited by 0position: contributordoi
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
2024cited by 716position: contributordoi
Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
2024cited by 301position: contributordoi
Global estimates on the number of people blind or visually impaired by glaucoma: A meta-analysis from 2000 to 2020
Eye 2024cited by 92position: middledoi
Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021.
2024cited by 81position: contributordoi
Targeting Hypoxia-Inducible Factor-1 (HIF-1) in Cancer: Emerging Therapeutic Strategies and Pathway Regulation.
2024cited by 60position: contributordoi
Global estimates on the number of people blind or visually impaired by age-related macular degeneration: a meta-analysis from 2000 to 2020
Eye 2024cited by 41position: middledoi
Liposome-Based Drug Delivery Systems in Cancer Research: An Analysis of Global Landscape Efforts and Achievements.
2024cited by 24position: contributordoi
Pomegranate peel: Bioactivities as antimicrobial and cytotoxic agents.
2024cited by 14position: contributordoi
Potential of CDC25 phosphatases in cancer research and treatment: key to precision medicine.
2024cited by 12position: contributordoi
Exploring the Potential of Rosemary Derived Compounds (Rosmarinic and Carnosic Acids) as Cancer Therapeutics: Current Knowledge and Future Perspectives.
2024cited by 11position: contributordoi
Metabolomics and Proteomics in Prostate Cancer Research: Overview, Analytical Techniques, Data Analysis, and Recent Clinical Applications.
2024cited by 10position: contributordoi
Fat mass and obesity-associated (FTO) gene is essential for insulin secretion and β-cell function: In vitro studies using INS-1 cells and human pancreatic islets.
2024cited by 8position: contributordoi
Association of proton pump inhibitor use with survival and adverse effects outcomes in patients with multiple myeloma: pooled analysis of three clinical trials.
2024cited by 4position: contributordoi
RETRACTED: Berberine Inhibited Growth and Migration of Human Colon Cancer Cell Lines by Increasing Phosphatase and Tensin and Inhibiting Aquaporins 1, 3 and 5 Expressions.
2023cited by 22position: contributordoi
Gold nanoparticles and breast cancer: A bibliometric analysis of the current state of research and future directions
OpenNano 2023cited by 19position: contributordoi
Evaluation of Two Simultaneous Metabolomic and Proteomic Extraction Protocols Assessed by Ultra-High-Performance Liquid Chromatography Tandem Mass Spectrometry.
2023cited by 17position: contributordoi
Mass spectrometry-based metabolomics approach and in vitro assays revealed promising role of 2,3-dihydroquinazolin-4(1H)-one derivatives against colorectal cancer cell lines.
2023cited by 15position: contributordoi
Skin Cancer Metabolic Profile Assessed by Different Analytical Platforms.
2023cited by 13position: contributordoi
Potential anticancer properties of calotropis procera: An investigation on breast and colon cancer cells.
2023cited by 10position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 39 papers (2019–2026)Eman Abu-Gharbieh · University of Sharjah15 papers (2022–2026)Mohammad H. Semreen · Universidade Nova de Lisboa15 papers (2022–2026)Waseem El-Huneidi · University of Waterloo15 papers (2022–2025) · 15 papers (2022–2026)Mohammad Alqudah · Springer Nature6 papers (2022–2023)Ahmad Y Abuhelwa · American Association of Colleges of Pharmacy5 papers (2022–2024)Nelson C. Soares · University of Cape Town5 papers (2022–2023)Mohamed A. Saleh · Ras al-Khaimah Medical and Health Sciences University3 papers (2022–2024)Ruba A. Zenati · American Association of Colleges of Pharmacy3 papers (2023–2026)Jalal Taneera · Elsevier, Inc.3 papers (2022–2025) · 3 papers (2022–2024)Mohammad Hudaib · University of Jordan3 papers (2021–2025)Walhan Alshaer · Université Paris-Saclay3 papers (2019–2025)Islam Hamad · 3 papers (2023–2025)Shtaywy Abdalla · Elsevier, Inc.3 papers (2022–2025)Sameh S. M. Soliman · The University of Texas Health Science Center2 papers (2022–2022)Karem H. Alzoubi · University College London2 papers (2023–2023)Hamza M. Al-Hroub · University of Sharjah2 papers (2023–2023)Hasan Y. Alniss · University of Toronto2 papers (2025–2026)